Nanotechnology-aided advancement in the combating of cancer metastasis

Leela Rani Avula1, Piotr Grodzinski2

  • 1Nanodelivery Systems and Devices Branch, Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. leelarani.avula@nih.gov.

Insights

Nanotechnology offers new strategies to combat metastatic cancer, a major cause of cancer deaths. These approaches target the metastatic cascade, improving identification and treatment of cancer spread.

Area of Science:

  • Oncology
  • Nanomedicine
  • Biotechnology

Background:

  • Metastatic cancer presents a significant clinical challenge, responsible for the majority of cancer-related mortality.
  • The metastatic cascade, a multi-step process of cancer cell dissemination, offers therapeutic targets.
  • Conventional diagnostic and treatment methods for metastatic cancer have limitations.

Purpose of the Study:

  • To explore the potential of nanotechnology in improving the identification and treatment of metastatic cancer.
  • To link nanotechnology-aided strategies with the biological steps of the metastatic cascade.
  • To discuss the translation of nanomedicine into clinical practice for metastatic cancer care.

Main Methods:

  • Comprehensive review of current literature on nanotechnology applications in cancer metastasis.
  • Analysis of how nanotechnology can address specific stages of the metastatic cascade.
  • Discussion of combined therapeutic approaches using nanotechnology and conventional methods.

Main Results:

  • Nanotechnology can enhance the targeting and efficacy of anti-metastatic therapies.
  • Specific nanotechnological strategies can be tailored to different steps of the metastatic cascade.
  • Nanomedicine holds promise for improved diagnostics and treatments for metastatic disease.

Conclusions:

  • Nanotechnology-aided approaches present significant potential to overcome challenges in treating metastatic cancer.
  • Targeting the metastatic cascade with nanomedicine can lead to novel anti-metastatic agents.
  • Translation of nanotechnology into patient care for metastatic cancer is progressing.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K